Asia-Pacific Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices

Description

List of Tables

GlobalData's "Asia-Pacific Neuromodulation Devices Outlook to 2033" is a comprehensive databook report, covering key market data on the Asia-Pacific Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Implantable Neuromodulation Devices, Minimally Invasive Neuromodulation Devices and Non-Invasive Neuromodulation Devices

The Asia-Pacific Neuromodulation Devices Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2025 company share data for Neuromodulation Devices Market.
Global corporate-level profiles of key companies operating within the Asia-Pacific Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia-Pacific Neuromodulation Devices is segmented as follows -

Implantable Neuromodulation Devices
Minimally Invasive Neuromodulation Devices
Non-Invasive Neuromodulation Devices

Reasons to Buy

The Asia-Pacific Neuromodulation Devices Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME21760CRDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Neuromodulation Devices Market, Asia-Pacific

3.1 Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), 2018-2033
3.2 Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), 2018-2033
3.3 Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033
3.4 Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033
3.5 Neuromodulation Devices Market, Asia-Pacific, Company Share by Revenue ($m), 2025

4 Neuromodulation Devices Market, Australia

4.1 Neuromodulation Devices Market, Australia, Revenue ($m), 2018-2033
- 4.1.1 Implantable Neuromodulation Devices Market, Australia, Revenue ($m), by Segment, 2018-2033
4.2 Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
- 4.2.1 Implantable Neuromodulation Devices Market, Australia, Volume (Units), by Segment, 2018-2033
4.3 Neuromodulation Devices Market, Australia, Average Price ($), 2018-2033
4.4 Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), 2025

5 Neuromodulation Devices Market, China

5.1 Neuromodulation Devices Market, China, Revenue ($m), 2018-2033
- 5.1.1 Implantable Neuromodulation Devices Market, China, Revenue ($m), by Segment, 2018-2033
5.2 Neuromodulation Devices Market, China, Volume (Units), 2018-2033
- 5.2.1 Implantable Neuromodulation Devices Market, China, Volume (Units), by Segment, 2018-2033
5.3 Neuromodulation Devices Market, China, Average Price ($), 2018-2033
5.4 Neuromodulation Devices Market, China, Company Share by Revenue ($m), 2025

6 Neuromodulation Devices Market, India

6.1 Neuromodulation Devices Market, India, Revenue ($m), 2018-2033
- 6.1.1 Implantable Neuromodulation Devices Market, India, Revenue ($m), by Segment, 2018-2033
6.2 Neuromodulation Devices Market, India, Volume (Units), 2018-2033
- 6.2.1 Implantable Neuromodulation Devices Market, India, Volume (Units), by Segment, 2018-2033
6.3 Neuromodulation Devices Market, India, Average Price ($), 2018-2033
6.4 Neuromodulation Devices Market, India, Company Share by Revenue ($m), 2025

7 Neuromodulation Devices Market, Japan

7.1 Neuromodulation Devices Market, Japan, Revenue ($m), 2018-2033
- 7.1.1 Implantable Neuromodulation Devices Market, Japan, Revenue ($m), by Segment, 2018-2033
7.2 Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
- 7.2.1 Implantable Neuromodulation Devices Market, Japan, Volume (Units), by Segment, 2018-2033
7.3 Neuromodulation Devices Market, Japan, Average Price ($), 2018-2033
7.4 Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), 2025

8 Neuromodulation Devices Market, South Korea

8.1 Neuromodulation Devices Market, South Korea, Revenue ($m), 2018-2033
- 8.1.1 Implantable Neuromodulation Devices Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.2 Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033
- 8.2.1 Implantable Neuromodulation Devices Market, South Korea, Volume (Units), by Segment, 2018-2033
8.3 Neuromodulation Devices Market, South Korea, Average Price ($), 2018-2033
8.4 Neuromodulation Devices Market, South Korea, Company Share by Revenue ($m), 2025

9 Overview of Key Companies in Asia-Pacific Neuromodulation Devices Market

9.1 Medtronic Plc
- 9.1.1 Company Overview
9.2 Boston Scientific Corp
- 9.2.1 Company Overview
9.3 LivaNova Plc
- 9.3.1 Company Overview
9.4 Abbott Laboratories
- 9.4.1 Company Overview
9.5 Nevro Corp
- 9.5.1 Company Overview
9.6 Beijing Pins Medical Co Ltd
- 9.6.1 Company Overview
9.7 Enterra Medical Inc
- 9.7.1 Company Overview

10 Neuromodulation Devices Market Pipeline Products

11 Recent Developments

11.1 Corporate Communications
- 11.1.1 Nov 18, 2025: NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD
- 11.1.2 Nov 11, 2025: Novel Technique Enhances Brain-State Detection
- 11.1.3 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
- 11.1.4 Oct 10, 2025: Nexalin Technology Attends the 2025 Maxim Growth Summit
- 11.1.5 Oct 06, 2025: GSK Appoints Luke Miels As CEO Designate
- 11.1.6 Sep 09, 2025: Pioneering Sustainability: Teijin Carbon Publishes Its First Sustainability Report
11.2 Financial Announcements
- 11.2.1 Feb 05, 2026: Nihon Kohden Announces Consolidated Financial Results for the Third Quarter of FY2025 ending March 31, 2026
- 11.2.2 Oct 14, 2025: FPH to Announce Half Year Results on 26 November 2025
- 11.2.3 Aug 05, 2025: Teijin Reports Results for Three Months Ended June 30, 2025
11.3 Government and Public Interest
- 11.3.1 Nov 07, 2025: Empowering National Medical Device Innovation and Promoting Industry Integration
- 11.3.2 Oct 10, 2025: Nexalin Technology Attends the 2025 Maxim Growth Summit
11.4 Other Significant Developments
- 11.4.1 Nov 24, 2025: NeuroPace Announces Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
- 11.4.2 Nov 07, 2025: Empowering National Medical Device Innovation and Promoting Industry Integration
- 11.4.3 Sep 29, 2025: PolyU And Zhejiang Qiangnao Technology Sign MOU To Explore Joint Research Centre For Brain-Computer Interface
11.5 Product News
- 11.5.1 Nov 28, 2025: Yale-Trained Neuroscientist Introduces Panbrain Lume "Digital Sunshine" Device to Improve Sleep
- 11.5.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
- 11.5.3 Nov 21, 2025: Brainbox and Sonic Concepts Deliver 100 NeuroFUS Systems Worldwide
- 11.5.4 Nov 15, 2025: Evidence Builds for Disrupted Mitochondria as Cause of Parkinson's
- 11.5.5 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
- 11.5.6 Nov 05, 2025: Nexalin Technology's Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for Alzheimer's Treatment
- 11.5.7 Oct 30, 2025: Nexalin Technology Receives Regulatory Approval for Gen 2 SYNC Neurostimulation Device in Israel
- 11.5.8 Oct 30, 2025: Sant Pau Incorporates MRgFUS Technology For Movement Disorders Without Surgery
- 11.5.9 Oct 24, 2025: IDE Group Announces Winner of the 2025 Building Better Futures for Health Challenge
- 11.5.10 Oct 21, 2025: Nexalin's DIFS Neurostimulation Demonstrates Cognitive Improvements in Alzheimer's and Dementia
- 11.5.11 Oct 20, 2025: Neupulse Attends Launch of N3 Centre for Neurotechnology
- 11.5.12 Oct 08, 2025: Nexalin Technology Reports Positive Clinical Results for Alzheimer's with Gen-2 SYNC Device
- 11.5.13 Oct 07, 2025: Oxeia Biopharmaceuticals Recognized As Most Innovative Mild Traumatic Brain Injury Company for 2025
- 11.5.14 Oct 01, 2025: BalanceWear(R) for Multiple Sclerosis: Enhance Stability and Mobility
- 11.5.15 Sep 29, 2025: Development of a Wireless Multifunctional Brain Oxygen Monitor for Rehabilitation and Daily Use
- 11.5.16 Sep 25, 2025: Nexalin Technology Issues U.S. Patent for HALO Clarity Device with DIFS Technology
- 11.5.17 Sep 17, 2025: Soft Bioelectronic Fiber Tracks Hundreds of Biological Events Simultaneously
- 11.5.18 Sep 10, 2025: Robotimize Showcases Hospital-to-Community Neurorehabilitation at AOCNR 2025 in Yogyakarta
- 11.5.19 Sep 10, 2025: Neurocare Group's Apollo TMS Therapy Devices Granted FDA Clearance for Treating Adolescent Depression
- 11.5.20 Mar 03, 2025: KYOCERA to Showcase Ceramic Lab Analytic Technologies for Multilayer Direct Bonding, Ceramic Additive Manufacturing, and Sapphire Apertures at Pittcon 2025
11.6 Research And Development
- 11.6.1 Sep 29, 2025: Development of a Wireless Multifunctional Brain Oxygen Monitor for Rehabilitation and Daily Use
11.7 Strategy And Business Planning
- 11.7.1 Nov 25, 2025: NaviFUS Presents Stroke Rehabilitation Data at AOCCN 2025
- 11.7.2 Nov 21, 2025: Brainbox and Sonic Concepts Deliver 100 NeuroFUS Systems Worldwide
- 11.7.3 Nov 13, 2025: Nexalin Technology Appoints Carmi Masha Technologies Ltd. As Exclusive Distributor In Israel
- 11.7.4 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
- 11.7.5 Oct 30, 2025: Nexalin Technology Receives Regulatory Approval for Gen 2 SYNC Neurostimulation Device in Israel
- 11.7.6 Oct 20, 2025: Neupulse Attends Launch of N3 Centre for Neurotechnology
- 11.7.7 Sep 29, 2025: PolyU And Zhejiang Qiangnao Technology Sign MOU To Explore Joint Research Centre For Brain-Computer Interface

12 Appendix

12.1 Research Methodology
- 12.1.1 Coverage
- 12.1.2 Secondary Research
- 12.1.3 Primary Research
- 12.1.4 Market Modeling and Forecasting
- 12.1.5 Company Share Analysis
- 12.1.6 Benchmarking
12.2 GlobalData Consulting
12.3 Contact Us
12.4 Disclaimer

Product Code: GDME21760CRDB

List of Table

List of Tables

Table 1: Neuromodulation Devices Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033
Table 2: Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033
Table 4: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033
Table 5: Neuromodulation Devices Market, Asia-Pacific, Company Share by Revenue ($m), 2025
Table 6: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 7: Implantable Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 8: Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
Table 9: Implantable Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
Table 10: Neuromodulation Devices Market, Australia, Average Price ($), 2018-2033
Table 11: Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), 2025
Table 12: Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Table 13: Implantable Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Table 14: Neuromodulation Devices Market, China, Volume (Units), 2018-2033
Table 15: Implantable Neuromodulation Devices Market, China, Volume (Units), 2018-2033
Table 16: Neuromodulation Devices Market, China, Average Price ($), 2018-2033
Table 17: Neuromodulation Devices Market, China, Company Share by Revenue ($m), 2025
Table 18: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033
Table 19: Implantable Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033
Table 20: Neuromodulation Devices Market, India, Volume (Units), 2018-2033
Table 21: Implantable Neuromodulation Devices Market, India, Volume (Units), 2018-2033
Table 22: Neuromodulation Devices Market, India, Average Price ($), 2018-2033
Table 23: Neuromodulation Devices Market, India, Company Share by Revenue ($m), 2025
Table 24: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 25: Implantable Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 26: Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
Table 27: Implantable Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
Table 28: Neuromodulation Devices Market, Japan, Average Price ($), 2018-2033
Table 29: Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), 2025
Table 30: Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 31: Implantable Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 32: Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033
Table 33: Implantable Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033
Table 34: Neuromodulation Devices Market, South Korea, Average Price ($), 2018-2033
Table 35: Neuromodulation Devices Market, South Korea, Company Share by Revenue ($m), 2025
Table 36: Neuromodulation Devices Market Pipeline Products
Table 37: Total Number of Primary Research Participants, Neurology Devices Market, by Country

List of Figure

List of Figures

Figure 1: Neuromodulation Devices Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033
Figure 2: Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033
Figure 4: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033
Figure 5: Neuromodulation Devices Market, Asia-Pacific, Company Share (%), 2025
Figure 6: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 7: Implantable Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 8: Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
Figure 9: Implantable Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033
Figure 10: Neuromodulation Devices Market, Australia, Company Share (%), 2025
Figure 11: Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 12: Implantable Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 13: Neuromodulation Devices Market, China, Volume (Units), 2018-2033
Figure 14: Implantable Neuromodulation Devices Market, China, Volume (Units), 2018-2033
Figure 15: Neuromodulation Devices Market, China, Company Share (%), 2025
Figure 16: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 17: Implantable Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 18: Neuromodulation Devices Market, India, Volume (Units), 2018-2033
Figure 19: Implantable Neuromodulation Devices Market, India, Volume (Units), 2018-2033
Figure 20: Neuromodulation Devices Market, India, Company Share (%), 2025
Figure 21: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 22: Implantable Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 23: Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
Figure 24: Implantable Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033
Figure 25: Neuromodulation Devices Market, Japan, Company Share (%), 2025
Figure 26: Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 27: Implantable Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 28: Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033
Figure 29: Implantable Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033
Figure 30: Neuromodulation Devices Market, South Korea, Company Share (%), 2025